Vertex Pharmaceuticals Inc (VRTX) Insider Trading
- $12,939,410.00
- $1,027,201,493.43
- March 10, 2025
- Joshua S Boger
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 2, 2015 | CMO | 2,291 | $115.50 | Sell | $264,610.50 | |
| April 1, 2015 | Director | 11,700 | $115.87 | Sell | $1,355,679.00 | |
| March 25, 2015 | Director | 11,700 | $120.76 | Sell | $1,412,892.00 | |
| March 23, 2015 | CFO | 6,042 | $125.67 | Sell | $759,298.14 | |
| March 23, 2015 | SVP | 2,250 | $125.65 | Sell | $282,712.50 | |
| March 23, 2015 | EVP | 17,083 | $132.28 | Sell | $2,259,739.24 | |
| March 18, 2015 | EVP | 12,000 | $130.00 | Sell | $1,560,000.00 | |
| Feb. 5, 2015 | SVP | 1,688 | $109.75 | Sell | $185,258.00 | |
| Feb. 4, 2015 | Director | 5,700 | $108.81 | Sell | $620,217.00 | |
| Feb. 3, 2015 | SVP | 2,063 | $108.89 | Sell | $224,640.07 | |
| Feb. 2, 2015 | CMO | 1,188 | $109.60 | Sell | $130,204.80 | |
| Jan. 28, 2015 | Director | 10,688 | $122.78 | Sell | $1,312,272.64 | |
| Jan. 26, 2015 | SVP | 1,125 | $125.62 | Sell | $141,322.50 | |
| Jan. 21, 2015 | Director | 10,500 | $125.08 | Sell | $1,313,340.00 | |
| Jan. 14, 2015 | Director | 10,500 | $120.16 | Sell | $1,261,680.00 | |
| Jan. 9, 2015 | Director | 9,861 | $125.04 | Sell | $1,233,019.44 | |
| Jan. 9, 2015 | EVP | 12,000 | $125.00 | Sell | $1,500,000.00 | |
| Jan. 7, 2015 | Director | 10,500 | $119.32 | Sell | $1,252,860.00 | |
| Jan. 2, 2015 | CMO | 2,291 | $122.54 | Sell | $280,739.14 | |
| Dec. 22, 2014 | Director | 10,500 | $117.65 | Sell | $1,235,325.00 | |
| Dec. 17, 2014 | Director | 10,500 | $110.66 | Sell | $1,161,930.00 | |
| Dec. 15, 2014 | CEO | 50,017 | $114.97 | Sell | $5,750,454.49 | |
| Dec. 12, 2014 | SVP | 2,813 | $120.08 | Sell | $337,785.04 | |
| Nov. 28, 2014 | SVP | 8,164 | $119.85 | Sell | $978,455.40 | |
| Nov. 28, 2014 | Director | 10,000 | $120.03 | Sell | $1,200,300.00 | |
| Nov. 28, 2014 | EVP | 12,000 | $120.00 | Sell | $1,440,000.00 | |
| Nov. 26, 2014 | Director | 10,500 | $114.54 | Sell | $1,202,670.00 | |
| Nov. 6, 2014 | Director | 9,900 | $115.21 | Sell | $1,140,579.00 | |
| Nov. 5, 2014 | Director | 30,100 | $112.62 | Sell | $3,389,862.00 | |
| Nov. 3, 2014 | Director | 127,411 | $112.20 | Sell | $14,295,514.20 | |
| Oct. 29, 2014 | Director | 10,500 | $109.44 | Sell | $1,149,120.00 | |
| Oct. 28, 2014 | CMO | 3,438 | $115.00 | Sell | $395,370.00 | |
| Oct. 28, 2014 | Director | 2,000 | $114.75 | Sell | $229,500.00 | |
| Oct. 28, 2014 | EVP | 12,000 | $115.00 | Sell | $1,380,000.00 | |
| Oct. 27, 2014 | SVP | 1,125 | $110.03 | Sell | $123,783.75 | |
| Oct. 13, 2014 | SVP | 1,125 | $107.89 | Sell | $121,376.25 | |
| Oct. 7, 2014 | CMO | 3,436 | $104.26 | Sell | $358,237.36 | |
| Oct. 6, 2014 | Director | 1,405 | $109.75 | Sell | $154,198.75 | |
| Oct. 1, 2014 | Director | 5,000 | $107.74 | Sell | $538,700.00 | |
| Oct. 1, 2014 | EVP | 12,417 | $107.71 | Sell | $1,337,435.07 | |
| Sept. 30, 2014 | SVP | 86,000 | $112.68 | Sell | $9,690,480.00 | |
| Sept. 30, 2014 | CFO | 108,026 | $112.68 | Sell | $12,172,369.68 | |
| Sept. 30, 2014 | CEO | 200,000 | $112.69 | Sell | $22,538,000.00 | |
| Sept. 30, 2014 | EVP | 36,000 | $112.69 | Sell | $4,056,840.00 | |
| Sept. 29, 2014 | Director | 2,500 | $114.75 | Sell | $286,875.00 | |
| Sept. 24, 2014 | Director | 5,200 | $109.21 | Sell | $567,892.00 | |
| Sept. 19, 2014 | Director | 5,000 | $102.25 | Sell | $511,250.00 | |
| Sept. 19, 2014 | SVP | 25,408 | $99.85 | Sell | $2,536,988.80 | |
| Sept. 19, 2014 | EVP | 55,521 | $100.00 | Sell | $5,552,100.00 | |
| Sept. 17, 2014 | Director | 5,200 | $93.62 | Sell | $486,824.00 |
Insiders are both buying and selling Vertex Pharmaceuticals Inc stock.
The insider traders at Vertex Pharmaceuticals Inc are: Joshua S Boger, Paul M Silva, Stuart A Arbuckle, Jeffrey M Leiden, Amit Sachdev, Michael Parini, Jeffrey Chodakewitz, David Altshuler, Joshua S. Boger, Yuchun Lee, Reshma Kewalramani, Sangeeta N Bhatia, Ourania Tatsis, Ian F Smith, Bastiano Sanna, Bruce I Sachs, Joshua Boger, Peter Mueller, Charles F Wagner Jr, Carmen Bozic, Margaret G Mcglynn, Bruce Sachs, Elaine Ullian, Stuart A. Arbuckle, Kristen Ambrose, Jeffrey Leiden, Joy Liu, Kenneth L Horton, Megan E Pace, Megan Pace, Wayne Joseph Riley, Paul Silva, Thomas Graney, Christiana Stamoulis, Kenneth Horton, Sangeeta N. Bhatia, Ian F. Smith, Paul M. Silva, Terrence C Kearney, Thomas Connolly, Jeffrey M. Leiden, William D Young, Jonathan Biller, Edward Morrow Atkinson III, and Lloyd Carney
The most active insider trader at Vertex Pharmaceuticals Inc is Joshua S Boger with 99 trades.
Jeffrey M Leiden has sold the most Vertex Pharmaceuticals Inc stock with a total value of $395,375,749.22.
Reshma Kewalramani has bought the most Vertex Pharmaceuticals Inc stock with a total value of $17,310,520.00.
The most recent insider trade for Vertex Pharmaceuticals Inc was on March 10, 2025.
The single biggest insider buy for Vertex Pharmaceuticals Inc was from Reshma Kewalramani with a total value of $7,677,010.00 on July 30, 2024.
The single biggest insider sell for Vertex Pharmaceuticals Inc was from Jeffrey M Leiden with a total value of $37,164,389.02 on July 25, 2022.